Hepatitis C Tests Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast to 2033

Hepatitis C Tests Market Report Overview

The Hepatitis C Tests market size was valued at $1.99 billion in 2022. Hepatitis C is a viral infection caused by the hepatitis C virus (HCV). Hepatitis C virus is a blood-borne virus that causes liver disease and can cause acute and chronic hepatitis. Infection may be caused through injection drug use, transfusion of unscreened blood products, unsafe injection practices, sexual contact, and from the infected mother to her baby.

Hepatitis C Tests Market Outlook 2022-2033 ($ Billion)

For more insights on the Hepatitis C Tests market forecast, download a free sample report

The Hepatitis C Tests market research report is built to visualize quantitative market trends within in vitro diagnostics therapeutic areas. Furthermore, the model discusses in detail the impact of COVID-19 on the Hepatitis C Tests market for the year 2020 and beyond.

Hepatitis C Tests Market Dynamics

During COVID Pandemic, due to social distancing measures and irregular hospital services including treatment and testing, HCV screening was reduced to a greater extent which may lead to a diagnosis of disease at later stages of HCV that could prove to be fatal for patients.  However, the global HCV tests market is expected to increase during the forecast period (post-pandemic time), with the strongest growth occurring in the North American and APAC regions. Strong gains are expected to occur in key markets such as the US and China, followed by India.

In each country, HCV test sales are influenced by a variety of different factors including fluctuations in disease incidence and prevalence, the number of pregnant women, sperm donations, whole blood donations, and source plasma donations.

For additional Hepatitis C Tests market dynamics, download a free sample report

Hepatitis C Tests Market Segments

The key segments in the Hepatitis C Tests market are Hepatitis Tests and Multi-parameter HIV, Hepatitis C, and Hepatitis C NAAT. In 2022, the Hepatitis C Tests segment dominated the market share.

Hepatitis C is a viral infection that causes liver inflammation and serious liver damage. Chronic hepatitis C virus (HCV) can be cured with oral medications taken for two to six months. The incidence of HCV is expected to remain stable in most countries during the forecast period. However, HCV incidence is expected to increase in the US, Canada, China, and Brazil, while incidence is decreasing in Germany, Australia, and New Zealand.

Hepatitis C Tests Market Analysis by Segments, 2022 (%)

To know more about the Hepatitis C Tests market segments, download a free sample report

Hepatitis C Tests Market Segmentation by Regions

The key regions in the Hepatitis C Tests market are Asia-Pacific, Europe, the Middle East and Africa, North America, and South and Central America. In 2022, North America emerged as the leading regional segment with the US being the largest contributor to the regional market.

Strong growth is expected to occur in the North American hepatitis C tests market over the next decade. The US and Canadian markets are both expected to increase, while a slight decline is forecast in the Mexican market. The number of hepatitis C tests performed for prevalent cases is expected to increase in all three North American countries, with the number of suspected infection cases also expected to increase in the US and Mexico. However, these are not the only drivers of market growth; a large proportion of tests are performed on pregnant women and donors of human cells, tissues, and cellular and tissue-based products.

Hepatitis C Tests Market Analysis by Regions, 2022 (%)

For more regional insights in the Hepatitis C Tests market, download a free sample report

Hepatitis C Tests Market – Competitive Landscape

The key players in the Hepatitis C Tests market are Abbott Laboratories, Bio-Rad Laboratories Inc, Hologic Inc, Quidel Corp, Bio Manguinhos and Fiocruz, Grifols SA, Roche Diagnostics International Ltd, Siemens Healthineers AG, Qiagen NV, bioMerieux SA, and DiaSorin SpA among others.

Hepatitis C Tests Market Analysis by Leading Companies, 2022 (%)

For more competitor insights in the Hepatitis C Tests market, download a free sample report

Segments Covered in this Report

Hepatitis C Tests Segment Outlook ($ Billion, 2015-2033)

• Hepatitis Tests
  • Hepatitis C Tests
• Multi-parameter HIV, Hepatitis C, and Hepatitis C NAAT
  • Overall

Hepatitis C Tests Regional Outlook ($ Billion, 2015-2033)

• Asia-Pacific
• Europe
• Middle East and Africa
• North America
• South and Central America

Key Inclusions of the market model are –

Currently marketed Hepatitis C Tests market and evolving competitive landscape –

• Insightful review of the key industry trends.
• Annualized total Hepatitis C Tests market revenue by segment and market outlooks from 2015-2033.
• Market-level data on units, average selling prices, and market values.

Global, Regional and Country level market specific insights –

• Qualitative market-specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
• SWOT analysis for the Hepatitis C Tests market.
• Competitive dynamics insights and trends provided for the Hepatitis C Tests market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country-specific overview of the healthcare system.
• Country-specific reimbursement policies.
• Country-specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real-world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Abbott Laboratories, Bio-Rad Laboratories Inc, Hologic Inc, Quidel Corp, Bio Manguinhos and Fiocruz, Grifols SA, Roche Diagnostics International Ltd, Siemens Healthineers AG, Qiagen NV, bioMerieux SA, and DiaSorin SpA among others.

Countries covered – United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for

• CMO executives who must have a deep understanding of the Hepatitis C Tests marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to –

• Understand the impact of COVID-19 on Hepatitis C Tests.
• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving Hepatitis C Tests.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Hepatitis C Tests market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company’s share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Hepatitis C Tests market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.